| Title | MedComm - Oncology |
| Abbreviation | MedComm - Oncol. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Oncology (Q3); Cancer Research (Q4); Cell Biology (Q4) |
| h-index | 6 |
| Overall Rank/Ranking | 13050 |
| SCImago Journal Rank (SJR) | 0.433 |
| Impact Score | 1.73 |
| Publisher | John Wiley and Sons Inc |
| Country | China |
| ISSN | 27696448 |
| Best Quartile | Q3 |
| Coverage History | 2022-2025 |
MedComm - Oncology is a journal covering the technologies/fields/categories related to Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Oncology (Q3); Cancer Research (Q4); Cell Biology (Q4). It is published by John Wiley and Sons Inc. The overall rank of MedComm - Oncology is 13050. According to SCImago Journal Rank (SJR), this journal is ranked 0.433. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 6. The best quartile for this journal is Q3.
The ISSN of MedComm - Oncology journal is 27696448. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. MedComm - Oncology is cited by a total of 85 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of MedComm - Oncology is 1.73, which is computed in 2025 as per its definition. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of MedComm - Oncology is 1.73. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.73 |
MedComm - Oncology has an h-index of 6. It means 6 articles of this journal have more than 6 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of MedComm - Oncology is 27696448. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of MedComm - Oncology is 13050. According to SCImago Journal Rank (SJR), this journal is ranked 0.433. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.433 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 13050 |
MedComm - Oncology is published by John Wiley and Sons Inc. It's publishing house is located in China. Coverage history of this journal is as following: 2022-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of MedComm - Oncology is MedComm - Oncol.. This abbreviation ('MedComm - Oncol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Oncology (Q3); Cancer Research (Q4); Cell Biology (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
MedComm - Oncology latest impact IF is 1.73. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 1.73 (2024) and 1.73 (2024), respectively, in the last 1 year. Moreover, its average IS is 1.73 in the previous 1 year.
The MedComm - Oncology has an SJR (SCImago Journal Rank) of 0.433, according to the latest data. It is computed in the year 2025. In the past 1 years, this journal has recorded a range of SJR, with the highest being 0.433 in 2024 and the lowest being 0.433 in 2024. Furthermore, the average SJR of the MedComm - Oncology over the previous 1-year period stands at 1.73.
The latest h-index of the MedComm - Oncology is 6.
The MedComm - Oncology is published by the John Wiley and Sons Inc, with its country of publication being the China.
The MedComm - Oncology is currently ranked 13050 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 1 year, this journal has experienced varying rankings, reaching its highest position of 13050 in 2024 and its lowest position of 13050 in 2024.
The standard ISO4 abbreviation for the MedComm - Oncology is MedComm - Oncol..
MedComm - Oncology is classified as a journal that the John Wiley and Sons Inc publishes.
The MedComm - Oncology encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The MedComm - Oncology is assigned the following International Standard Serial Numbers (ISSN): 27696448.
The best quartile for the MedComm - Oncology is Q3 (2024).
The MedComm - Oncology coverage history can be summarized as follows: 2022-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Analysis in Theory and Applications | journal | 19346 | Springer Netherlands | 11 | 0.00 |
| Materials Research | journal | 15597 | Universidade Federal de Sao Carlos | 75 | 1.40 |
| International Journal of Parallel, Emergent and Distributed Systems | journal | 17452 | Taylor and Francis Ltd. | 27 | 1.17 |
| Marine Biology Research | journal | 14618 | Taylor and Francis Ltd. | 47 | 1.21 |
| Canadian Journal of Education | journal | 15557 | Canadian Society for the Study of Education (CSSE) | 46 | 0.80 |
| Howard Journal of Communications | journal | 14582 | Taylor and Francis Ltd. | 42 | 1.27 |
| Korean Journal of Applied Microbiology and Biotechnology | journal | 22033 | Korean Society for Applied Microbiology | 0 | 0.00 |
| Statistica | journal | 18529 | University of Bologna | 9 | 0.38 |
| Proceedings of the International Semiconductor Conference, CAS | conference and proceedings | 25734 | Institute of Electrical and Electronics Engineers Inc. | 16 | 0.00 |
| Built Environment | journal | 16252 | Alexandrine Press | 51 | 0.95 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.73 |
